Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo C49 English + 你好 (nǐ hǎo) = limitless possibilities. Start learning Mandarin Chinese today—for free, forever. Amedeo C49 is completely free, for life. Next week: +49.

Malignant Lymphoma

Free Subscription Articles published in J Natl Cancer Inst Retrieve available abstracts of 12 articles: HTML format

Single Articles

October 2025
1. CHOKUNONGA E, Makunike-Mutasa R, Borok M, Chirenje MZ, et al
   Trends in the incidence of cancers related to HIV-AIDS in Harare, Zimbabwe 1990-2019.
   J Natl Cancer Inst. 2025;117:2096-2102.
   PubMed     Abstract available
   
   
   September 2025
2. YAMSHON S, Leonard JP
   Unstacking the deck in follicular lymphoma clinical trials.
   J Natl Cancer Inst. 2025 Sep 12:djaf231. doi: 10.1093.
   PubMed    
   
   
   
3. KELLY RL, Machiela MJ
   Clones and clots in lymphoma transplant survivors.
   J Natl Cancer Inst. 2025 Sep 11:djaf211. doi: 10.1093.
   PubMed    
   
   
   July 2025
4. WILLIAMS AM, Rodday AM, Renfro LA, Wu Y, et al
   Group-based trajectories of health-related quality of life among pediatric patients with high-risk Hodgkin lymphoma.
   J Natl Cancer Inst. 2025 Jul 23:djaf197. doi: 10.1093.
   PubMed     Abstract available
   
   
   
5. WONG KSQ, Martynchyk A, Krisnadi Z, Swain F, et al
   Meeting trial eligibility in follicular lymphoma patients is associated with overall survival but not progression-free survival.
   J Natl Cancer Inst. 2025 Jul 10:djaf174. doi: 10.1093.
   PubMed     Abstract available
   
   
   
6. GANGARAJU R, Chen Y, Hageman L, Bosworth A, et al
   Clonal hematopoiesis and subsequent venous thromboembolism among survivors of autologous transplantation for lymphoma.
   J Natl Cancer Inst. 2025 Jul 2:djaf164. doi: 10.1093.
   PubMed     Abstract available
   
   
   January 2025
7. MEZGER NCS, Seraphin TP, Balle R, Griesel M, et al
   NCCN guideline-concordant cancer care in sub-Saharan Africa: a population-based multicountry study of 5 cancers.
   J Natl Cancer Inst. 2025;117:120-133.
   PubMed     Abstract available
   
   
   November 2024
8. ROBERTI S, van Leeuwen FE, Diallo I, de Vathaire F, et al
   Prediction of breast cancer risk for adolescents and young adults with Hodgkin lymphoma.
   J Natl Cancer Inst. 2024 Nov 1:djae274. doi: 10.1093.
   PubMed     Abstract available
   
   
   July 2024
9. SCHAFER ES, Rushing T, Crews KR, Annesley C, et al
   Optimizing early phase clinical trial washout periods: a report from the therapeutic advances in childhood leukemia and lymphoma (TACL) consortium.
   J Natl Cancer Inst. 2024 Jul 4:djae165. doi: 10.1093.
   PubMed     Abstract available
   
   
   January 2024
10. WYATT KD, Birz S, Castellino SM, Henderson TO, et al
    Accelerating pediatric hodgkin lymphoma research: the hodgkin lymphoma data collaboration (NODAL).
    J Natl Cancer Inst. 2024 Jan 25:djae013. doi: 10.1093.
    PubMed     Abstract available
    
    
    November 2023
11. SIEGEL DA, King JB, Lupo PJ, Durbin EB, et al
    Counts, incidence rates, and trends of pediatric cancer in the United States, 2003-2019.
    J Natl Cancer Inst. 2023;115:1337-1354.
    PubMed     Abstract available
    
    
    September 2023
12. 
    Correction to: Mortality among patients with diffuse large B-cell lymphoma and mental disorders: a population-based study.
    J Natl Cancer Inst. 2023 Sep 22:djad199. doi: 10.1093.
    PubMed    
    
    

Thank you for your interest in scientific medicine.

AMEDEO Malignant Lymphoma is free of charge.